Number | Gender | Age | Location | Size (mm) | cStage | RT (gray/fraction) | CT | Adverse events (CTCAE v4.0) | SCC Ag before CRT | SCC Ag after CRT | Operation | Response | Prognosis |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 54 | Rb | 21.5 | III B | 59.4/33 | S-1 alone | None | 9.3 | 0.9 | - | CR | Disease-free for 3 years 8 months |
2 | F | 84 | Rb | 42.6 | II A | 59.4/33 | S-1 alone | None | 6.8 | 0.9 | - | CR | Disease-free for 2 years 1 month |
3 | F | 62 | Rb-a | 44.4 | III C | 45/25 | S-1 alone | Hemorrhage (G-3) | 54.3 | 1.2 | PPE | pCR | Bone and liver metastasis at 1 year 2 months |
Rb | 125 |